Lower usual and fast gait speeds are associated with higher one-year mortality in patients with head and neck cancer. A simple guideline is that patients with usual and fast GS <1 m/s or < p25 have a twofold higher risk of dying within one year compared to patients who walk faster.
Spruijt et al. (Wed,) studied this question.